ANAPTYSBIO INC. - COMMON STOCK
26.34
02-May-24 14:59:54
15 minutes delayed
Stocks
+0.32
+1.23%
Today's range
24.75 - 26.74
ISIN
N/A
Source
NASDAQ
-
AnaptysBio to Participate at the Cowen and Company 43rd Annual Health Care Conference
27 Feb 2023 15:05:01 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Stock Repurchase Plan
13 Jan 2023 08:00:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
05 Jan 2023 15:05:00 By Nasdaq GlobeNewswire
-
02 Dec 2022 08:00:00 By Nasdaq GlobeNewswire
-
AnaptysBio to Participate at the Piper Sandler 34th Annual Healthcare Conference
21 Nov 2022 12:56:39 By Nasdaq GlobeNewswire
-
AnaptysBio to Participate in Upcoming November Investor Conferences
09 Nov 2022 13:10:17 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Third Quarter 2022 Financial Results and Provides Pipeline Update
08 Nov 2022 15:05:01 By Nasdaq GlobeNewswire
-
05 Oct 2022 08:00:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Sale of Zejula Royalties for Up To $45 Million
12 Sep 2022 06:30:00 By Nasdaq GlobeNewswire
-
31 Aug 2022 15:15:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Second Quarter 2022 Financial Results and Provides Pipeline Update
08 Aug 2022 15:05:03 By Nasdaq GlobeNewswire
-
AnaptysBio to Participate at the 2022 Wedbush PacGrow Healthcare Virtual Conference
05 Aug 2022 15:00:00 By Nasdaq GlobeNewswire
-
AnaptysBio to Participate at the 2022 Jefferies Healthcare Conference
02 Jun 2022 15:05:01 By Nasdaq GlobeNewswire
-
AnaptysBio Announces First Quarter 2022 Financial Results and Provides Pipeline Update
04 May 2022 15:15:01 By Nasdaq GlobeNewswire
-
27 Apr 2022 15:15:00 By Nasdaq GlobeNewswire
-
AnaptysBio Appoints Daniel Faga As Interim Chief Executive Officer
21 Mar 2022 15:15:00 By Nasdaq GlobeNewswire
-
AnaptysBio Reports Imsidolimab ACORN Phase 2 Clinical Trial Data in Moderate-to-Severe Acne
14 Mar 2022 15:20:00 By Nasdaq GlobeNewswire
-
07 Mar 2022 07:50:00 By Nasdaq GlobeNewswire
-
AnaptysBio To Present at the 40th Annual J.P. Morgan Healthcare Conference
05 Jan 2022 15:05:00 By Nasdaq GlobeNewswire
-
AnaptysBio Announces Appointment of Daniel Faga to Board of Directors
29 Nov 2021 15:05:50 By Nasdaq GlobeNewswire